# Appendix: source tables

### Table: 0_coadread_tcga_pan_can_atlas_2018_clinical_data.tsv

| Field | Type | Most freq. value | Comment |
| --- | --- | --- | --- |
| study id | VARCHAR | coadread_tcga_pan_can_atlas_2018 |  |
| patient id | VARCHAR | TCGA-AA-3488 |  |
| sample id | VARCHAR | TCGA-D5-6531-01 |  |
| diagnosis age | VARCHAR | 68 |  |
| neoplasm disease stage american joint committee on cancer code | VARCHAR | STAGE IIA |  |
| american joint committee on cancer publication version type | VARCHAR | 6TH |  |
| aneuploidy score | VARCHAR | 0 |  |
| buffa hypoxia score | VARCHAR | NA |  |
| cancer type | VARCHAR | Colorectal Cancer |  |
| tcga pancanatlas cancer type acronym | VARCHAR | COAD |  |
| cancer type detailed | VARCHAR | Colon Adenocarcinoma |  |
| last communication contact from initial pathologic diagnosis date | VARCHAR | NA |  |
| birth from initial pathologic diagnosis date | VARCHAR | -32871 |  |
| last alive less initial pathologic diagnosis date calculated day value | VARCHAR | 0 |  |
| disease free (months) | VARCHAR | NA |  |
| disease free status | VARCHAR | NA |  |
| months of disease-specific survival | VARCHAR | 0 |  |
| disease-specific survival status | VARCHAR | 0:ALIVE OR DEAD TUMOR FREE |  |
| ethnicity category | VARCHAR | Not Hispanic Or Latino |  |
| form completion date | VARCHAR | 5/18/10 |  |
| fraction genome altered | VARCHAR | NA |  |
| genetic ancestry label | VARCHAR | EUR |  |
| neoplasm histologic grade | VARCHAR | NA |  |
| neoadjuvant therapy type administered prior to resection text | VARCHAR | No |  |
| icd-10 classification | VARCHAR | C18.7 |  |
| international classification of diseases for oncology, third edition icd-o-3 histology code | VARCHAR | 8140/3 |  |
| international classification of diseases for oncology, third edition icd-o-3 site code | VARCHAR | C18.7 |  |
| in pancan pathway analysis | VARCHAR | Yes |  |
| informed consent verified | VARCHAR | Yes |  |
| msi mantis score | VARCHAR | NA |  |
| msisensor score | VARCHAR | 0 |  |
| mutation count | VARCHAR | NA |  |
| new neoplasm event post initial therapy indicator | VARCHAR | No |  |
| oncotree code | VARCHAR | COAD |  |
| overall survival (months) | VARCHAR | 0 |  |
| overall survival status | VARCHAR | 0:LIVING |  |
| other patient id | VARCHAR | NA |  |
| american joint committee on cancer metastasis stage code | VARCHAR | M0 |  |
| neoplasm disease lymph node stage american joint committee on cancer code | VARCHAR | N0 |  |
| american joint committee on cancer tumor stage code | VARCHAR | T3 |  |
| person neoplasm cancer status | VARCHAR | With Tumor |  |
| progress free survival (months) | VARCHAR | 0 |  |
| progression free status | VARCHAR | 0:CENSORED |  |
| primary lymph node presentation assessment | VARCHAR | Yes |  |
| prior diagnosis | VARCHAR | No |  |
| race category | VARCHAR | White | Keep original values in Race category |
| radiation therapy | VARCHAR | No |  |
| ragnum hypoxia score | VARCHAR | NA |  |
| number of samples per patient | INT | 1 |  |
| sample type | VARCHAR | Primary |  |
| sex | VARCHAR | Male |  |
| somatic status | VARCHAR | Matched |  |
| subtype | VARCHAR | COAD_CIN |  |
| tumor break load | VARCHAR | 23 |  |
| tissue prospective collection indicator | VARCHAR | No |  |
| tissue retrospective collection indicator | VARCHAR | Yes |  |
| tissue source site | VARCHAR | Indivumed |  |
| tissue source site code | VARCHAR | AA |  |
| tmb (nonsynonymous) | VARCHAR | NA |  |
| tumor disease anatomic site | VARCHAR | Colon |  |
| tumor type | VARCHAR | Colon Adenocarcinoma |  |
| patient weight | VARCHAR | NA |  |
| winter hypoxia score | VARCHAR | NA |  |

